Gossamer Bio, Inc.
GOSS
$2.41
-$0.05-2.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.46% | -10.93% | -7.23% | -162.57% | 217.42% |
| Total Depreciation and Amortization | -37.72% | -68.19% | -2.09% | 10.69% | 0.61% |
| Total Amortization of Deferred Charges | 1.66% | 1.26% | 1.71% | -27.10% | 9.56% |
| Total Other Non-Cash Items | 345.04% | -114.67% | 19.95% | -25.85% | -34.81% |
| Change in Net Operating Assets | -190.23% | 38.62% | -37.03% | -106.35% | 533.01% |
| Cash from Operations | -18.47% | -11.96% | -10.76% | -127.53% | 322.45% |
| Capital Expenditure | -103.85% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.01% | -58.49% | 298.91% | 54.74% | -195.85% |
| Cash from Investing | 100.01% | -58.54% | 298.91% | 54.74% | -195.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | -233.38% |
| Issuance of Common Stock | -81.35% | -- | -100.00% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | -- |
| Cash from Financing | -81.35% | -- | -100.00% | 103.05% | -260.63% |
| Foreign Exchange rate Adjustments | 22.86% | 184.00% | -234.41% | 1,262.50% | 87.10% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.10% | -196.84% | 130.15% | -221.66% | 610.90% |